The number of glaucoma sufferers rises every year,1 as has the advent of new technology with which to treat this disease.
While articles and discussions on minimally invasive glaucoma surgery (MIGS) seem to be everywhere (for better or worse), “trabeculectomy will survive,” said Kuldev Singh, MD, because of the aging population, the ease of postoperative tit
While MIGS has forever changed the surgical management of glaucoma, the space continues to evolve.
Postoperative complications can have multiple causes and preventative measures
Surgeons can anticipate flurry of product releases that will drive innovation
Surgeon sheds light on his experiences with variety of innovative surgery options
Treatment options expand for patients along continuum of mild-to-severe disease
Surgical strategies can minimize risk by selecting appropriate patient, optimizing intraoperative view
A continuous, healthy exchange of clinical information and new ideas takes place between glaucoma surgeons in the United States and Europe every day.
As more microinvasive glaucoma surgery (MIGS) procedures become available, surgeons are faced with decisions on adoption of new techniques.